awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36066514-34E72E9B-17AC-4370-A209-C572D13B010B
Q36066514-34E72E9B-17AC-4370-A209-C572D13B010B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36066514-34E72E9B-17AC-4370-A209-C572D13B010B
Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirin
P2860
Q36066514-34E72E9B-17AC-4370-A209-C572D13B010B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36066514-34E72E9B-17AC-4370-A209-C572D13B010B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5ea5e67aea2103a56d233cca49f83c1886e813e6
P2860
Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients